According to TheFly, the brokerage also raised the price target for the stock to $250 from $213.
Although companies such as Tesla, Rivian and legacy automakers such as Ford and GM have dominated headlines this year, these lesser known brands captivated Stocktwits users more in Q1 2025.
Despite this, the company said it does not expect any significant changes in its financial results for fiscal year 2024.
Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle.
The liquefied natural gas firm intends to use the net proceeds from the offering to fund its purchase of New Fortress Energy’s Jamaica assets.
Sessa Capital, a hedge fund that has built a 1% stake in the company, has sought expansion of the board and expediting restructuring initiatives.
The company is currently exploring its strategic options, and it has employed advisors to help it determine the best course of action. The sale is estimated to fetch up to $2 billion.
For fiscal 2025, PVH expects revenue to be flat to slightly higher compared to 2024 on both a reported and constant currency basis.
The company said it is working to get the licenses of all its other nuclear units, with plans to submit a license renewal application for Robinson Nuclear Plant in Hartsville, S.C., this month.
The Ontario, Canada-based company is expected to report break-even bottom-line results and revenue of $132.81 million for the fourth quarter of the fiscal year 2025.
